Medicare Enrolled

Dr. Jayakumar Vidhun, M.D.

Internal Medicine · Whittier, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
12462 PUTNAM ST., Whittier, CA 90602
5626988141
In practice since 2007 (19 years)
NPI: 1275685638 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Vidhun from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Vidhun? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Vidhun

Dr. Jayakumar Vidhun is an internal medicine specialist in Whittier, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Vidhun performed 1,986 Medicare services across 828 unique beneficiaries.

Between the years covered by Open Payments, Dr. Vidhun received a total of $386,536 from 25 pharmaceutical and/or device companies across 772 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Vidhun is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 16% volume in CA $386,536 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,986
Medicare services
Top 16% in CA for internal medicine
828
Unique beneficiaries
$101
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~105 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
848 $66 $195
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
397 $90 $170
Dialysis services for patients 20 or older
Dialysis treatment provided to patients aged 20 years or older, involving four or more physician visits per month.
156 $298 $700
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
134 $107 $370
Nursing facility visit, low complexity
A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care.
120 $58 $185
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
69 $97 $285
Dialysis services for adults, 2-3 visits per month
This code covers dialysis services for patients aged 20 or older who have 2 to 3 physician visits per month.
66 $245 $600
Hospital discharge day management, 30 minutes or less
This service covers the final day of hospital care when the patient is being discharged. It includes coordination of care and instructions for the patient within a time frame of 30 minutes or less.
39 $68 $195
Initial nursing facility care, moderate complexity
Initial care provided to a patient in a nursing facility with moderate medical decision making, taking at least 35 minutes.
39 $110 $355
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
37 $137 $281
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
20 $33 $43
Flu vaccine, high-dose
High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe.
19 $71 $135
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
16 $73 $110
Hemodialysis, single evaluation
A dialysis procedure to filter waste from the blood, performed with a physician's evaluation.
15 $57 $155
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
11 $145 $545
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$386,536
Total received (2018-2024)
Avg $55,219/year across 7 years
Top 1% in CA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
25
Companies
772
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$378,283 (97.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$6,611 (1.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,643 (0.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$80,441
2023
$102,077
2022
$49,048
2021
$40,046
2020
$29,707
2019
$59,758
2018
$25,459

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Otsuka America Pharmaceutical, Inc.
$36,141
AstraZeneca Pharmaceuticals LP
$29,309
Mallinckrodt Hospital Products Inc.
$12,523
CALLIDITAS THERAPEUTICS US INC.
$2,102
GlaxoSmithKline, LLC.
$120
Ardelyx, Inc.
$65
Travere Therapeutics, Inc.
$61
Novo Nordisk Inc
$36
Otsuka Pharmaceutical Development & Commercialization, Inc.
$35
Novartis Pharmaceuticals Corporation
$26
Sumitomo Pharma America, Inc.
$22
Top 3 companies account for 96.9% of 2024 payments
All-time payments by company (2018-2024) ›
Otsuka America Pharmaceutical, Inc.
$278,452
AstraZeneca Pharmaceuticals LP
$83,452
Mallinckrodt Hospital Products Inc.
$14,291
CALLIDITAS THERAPEUTICS US INC.
$4,125
Mallinckrodt LLC
$4,103
Otsuka Pharmaceutical Development & Commercialization, Inc.
$903
Amgen Inc.
$191
GlaxoSmithKline, LLC.
$179
Travere Therapeutics, Inc.
$143
Horizon Pharma plc
$125
GENZYME CORPORATION
$109
Relypsa, Inc.
$69
Ardelyx, Inc.
$65
Aurinia Pharma U.S., Inc.
$45
Mallinckrodt Enterprises LLC
$44
Novo Nordisk Inc
$36
Calliditas Therapeutics US Inc.
$35
Fresenius USA Marketing, Inc.
$33
Novartis Pharmaceuticals Corporation
$26
Bayer Healthcare Pharmaceuticals Inc.
$23
Sumitomo Pharma America, Inc.
$22
E.R. Squibb & Sons, L.L.C.
$20
Bayer HealthCare Pharmaceuticals Inc.
$17
PFIZER INC.
$17
ARBOR PHARMACEUTICALS, INC.
$14
Top 3 companies account for 97.3% of all-time payments
Associated products mentioned in payments ›
ACTHAR · Aimovig · BENLYSTA · ELIQUIS · FABRAZYME · FARXIGA · GEMTESA · Horizant · IBSRELA · JESDUVROQ · JYNARQUE · KRYSTEXXA · Kerendia · LOKELMA · LUPKYNIS · Ozempic · SAMSCA · SHINGRIX · TARPEYO · TOLVAPTAN · Tavneos · Velphoro · Veltassa · Wegovy
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (98%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in internal medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for internal medicine in CA.

Looking for an internal medicine specialist in Whittier?
Compare internal medicine physicians in the Whittier area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians within 10 mi
4,911
Per 100K population
49.9
County median income
$87,760
Nearest hospital
PIH HEALTH HOSPITAL-WHITTIER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Vidhun is a clinical cardiology specialist, with above-average Medicare volume (top 16% in CA), with speaking/promotional industry engagement in the top 1% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Vidhun experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Vidhun performed 848 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Vidhun receive payments from pharmaceutical companies?
Yes. Dr. Vidhun received a total of $386,536 from 25 companies across 772 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Vidhun's costs compare to other internal medicine physicians in Whittier?
Dr. Vidhun's average Medicare payment per service is $101. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Vidhun) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →